A Review of Food Bioactives That Can Modulate miRNA Profiles for Management of Colorectal Cancer

Xiaoqin Wan1, Tolulope Joshua Ashaolu2,3, Mao-Cheng Sun4

  • 1College of Food Science and Engineering, Jilin University, Changchun 130062, China.

PubMed

Insights

Dietary bioactive compounds can regulate microRNAs (miRNAs) to combat colorectal cancer (CRC). This review explores how food components influence CRC progression and treatment by modulating specific miRNAs.

Area of Science:

  • Oncology
  • Molecular Biology
  • Nutritional Science

Background:

  • Colorectal cancer (CRC) is a leading global cancer with high mortality, requiring novel therapeutic strategies.
  • MicroRNAs (miRNAs) are key regulators of gene expression involved in various cellular processes, including cancer development.
  • Food-derived bioactive components show potential in modulating cellular processes relevant to CRC prevention and management.

Purpose of the Study:

  • To review the role of miRNAs in colorectal cancer.
  • To summarize the effects of food bioactive components on CRC through miRNA modulation.
  • To explore the potential of dietary interventions for CRC treatment and prevention.

Main Methods:

  • Literature review of studies on miRNAs, colorectal cancer, and food bioactive components.
  • Analysis of mechanisms by which food components modulate miRNA expression.
  • Synthesis of evidence on the anti-inflammatory, antioxidant, and pro-apoptotic effects of bioactive compounds via miRNAs.

Main Results:

  • miRNAs play a crucial role in CRC onset, progression, metastasis, and treatment response.
  • Specific food components, such as curcumin and resveratrol, can modulate key miRNAs in CRC cells.
  • Bioactive food components influence CRC cell proliferation, apoptosis, and drug sensitivity by regulating target proteins and pathways.

Conclusions:

  • Dietary therapy and preventive approaches targeting miRNA expression offer promising new directions for CRC management.
  • Modulating specific miRNAs through diet can impact CRC cellular behavior and therapeutic outcomes.
  • Further research into food-derived bioactive components and their miRNA-mediated effects holds potential for novel CRC treatments.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
2.9K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
236
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
102